1 year return (CAGR)
-25.09%
Vanda Pharmaceuticals Inc Exchange (NASDAQ, USD)
VNDA
4.05
-0.21 (-4.95%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-3.75%
5 year return (CAGR)
-25.94%
10 year return (CAGR)
-13.32%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
243.66M
Price/Sales
1.13
Ent value
380.06M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.25 |
| Daily high | 4.27 |
| Daily low | 4.00 |
| Daily Volume | 1.05M |
| All-time high | 31.67 |
| 1y analyst estimate | 11.75 |
| Beta | 0.65 |
| EPS (TTM) | -4.56 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 6 May 2026 |
Downside potential
Loading...
Downside potential data
| VNDA | S&P500 | |
| Current price drop from All-time high | -87.21% | -1.25% |
| Highest price drop | -98.42% | -56.47% |
| Date of highest drop | 31 Dec 2008 | 9 Mar 2009 |
| Avg drop from high | -65.40% | -10.65% |
| Avg time to new high | 224 days | 12 days |
| Max time to new high | 4964 days | 1805 days |
News
